Profitability Ratios
| Ratio |
Value |
| GP Margin |
-7.1% |
| EBIT Margin |
-1392.9% |
| EBITDA Margin |
-1357.8% |
| Operating Margin |
-883.3% |
| Pretax Margin |
-1392.9% |
| Cont. Ops Margin |
-1392.6% |
| Net Margin |
-1392.6% |
| Bottom Line Margin |
-1392.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
5.88 |
| Quick Ratio |
4.74 |
| Solvency Ratio |
-0.487 |
| Cash Ratio |
3.66 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
1.29 |
| Forward PEG |
1.29 |
| Price/Book |
-284.80 |
| Price/Sales |
1362.74 |
| Price/FCF |
-101.20 |
| Price/Op Cash Flow |
-123.29 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0005 |
| Debt/Equity |
-0.0024 |
| Debt/Capital |
-0.0024 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
-4.83 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.11 |
| Operating Cash Flow Ratio |
-4.014 |
| Operating Cash Flow/Sales |
-1105.3% |
| Free Cash Flow/Operating Cash Flow |
121.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.00 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
-975.27 |
| Capital Expenditure Coverage |
-4.58 |
| Dividend + Capital Expenditure Coverage |
-4.58 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.01 |
| EPS |
-0.125 |
| Debt/Share |
0.0001 |
| Cash/Share |
0.09 |
| Book Value/Share |
-0.04 |
| Tangible BV/Share |
-0.08 |
| Equity/Share |
-0.04 |
| Operating Cash Flow/Share |
-0.099 |
| Capital Expenditure/Share |
0.022 |
| FCF/Share |
-0.120 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
1.577 |
| Price/Fair Value |
-284.80 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
-99.63 |
YDES - YD Bio Limited Ordinary Shares